Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hamon

Showing results (611-620 of 635) with videos related to

Pageof 64
Sort By:
British Journal of Haematology|April 12, 2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)M Michallet, A Thiébaut, P Dreger, et al.
Circulation|December 29, 2005
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in miceA Mekontso-Dessap, F Brouri, O Pascal, et al.
Annales De Cardiologie Et D'Angeiologie|January 31, 2003
[Treatment of refractory cardiac insufficiency by peritoneal ultrafiltration. Literature review]E Lécluse, J P Ryckelink, T Lobbedez, et al.
Molecular Psychiatry|July 20, 2011
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant responseA Bacq, L Balasse, G Biala, et al.
Journal of Medicinal Chemistry|March 26, 1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivativesA Cappelli, M Anzini, S Vomero, et al.
Circulation|July 1, 1997
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stentingC Amant, C Bauters, J C Bodart, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 6, 2001
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitizationN Froger, A M Gardier, R Moratalla, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 7, 2001
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out miceN Salichon, P Gaspar, A L Upton, et al.
Molecular Psychiatry|September 7, 2011
Epigenetic regulation of the BDNF gene: implications for psychiatric disordersF Boulle, D L A van den Hove, S B Jakob, et al.
Molecular Psychiatry|January 23, 2002
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorderC Betancur, M Corbex, C Spielewoy, et al.
Pageof 64

Showing results (611-620 of 635) with videos related to

Sort By:
Pageof 64
British Journal of Haematology|April 12, 2000
Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukaemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukaemias Working Party (CLWP)M Michallet, A Thiébaut, P Dreger, et al.
Circulation|December 29, 2005
Deficiency of the 5-hydroxytryptamine transporter gene leads to cardiac fibrosis and valvulopathy in miceA Mekontso-Dessap, F Brouri, O Pascal, et al.
Annales De Cardiologie Et D'Angeiologie|January 31, 2003
[Treatment of refractory cardiac insufficiency by peritoneal ultrafiltration. Literature review]E Lécluse, J P Ryckelink, T Lobbedez, et al.
Molecular Psychiatry|July 20, 2011
Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant responseA Bacq, L Balasse, G Biala, et al.
Journal of Medicinal Chemistry|March 26, 1998
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivativesA Cappelli, M Anzini, S Vomero, et al.
Circulation|July 1, 1997
D allele of the angiotensin I-converting enzyme is a major risk factor for restenosis after coronary stentingC Amant, C Bauters, J C Bodart, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 6, 2001
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitizationN Froger, A M Gardier, R Moratalla, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 7, 2001
Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out miceN Salichon, P Gaspar, A L Upton, et al.
Molecular Psychiatry|September 7, 2011
Epigenetic regulation of the BDNF gene: implications for psychiatric disordersF Boulle, D L A van den Hove, S B Jakob, et al.
Molecular Psychiatry|January 23, 2002
Serotonin transporter gene polymorphisms and hyperserotonemia in autistic disorderC Betancur, M Corbex, C Spielewoy, et al.
Pageof 64